Verve Therapeutics Inc (VERV) stock has fallen -45.24% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives VERV stock a score of 35 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 5. VERV's rank also includes a long-term technical score of 5.
VERV has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on VERV!
Verve Therapeutics Inc (VERV) stock has risen 4.52% while the S&P 500 has risen 0.4% as of 11:39 AM on Monday, Nov 20. VERV has risen $0.53 from the previous closing price of $11.73 on volume of 764,071 shares. Over the past year the S&P 500 is up 14.74% while VERV has fallen -45.24%. VERV lost -$3.10 per share in the over the last 12 months.
Click Here to get the full Stock Report for Verve Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
